An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup / Viking Therapeutics closer to bringing its Ozempic competitor to market / Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup / Ozempic competitor in the works at Amgen reaches late-stage clinical trials / Woman on Ozempic switched to chia seeds, this was the result / The copycat brands that are replacing Ozempic in Russia / Hims & Hers can't sell off-brand Ozempic forever. But it can still sell these weight loss drugs / Healthy Returns: Ozempic helps curb alcohol use in new study -- and doctors are concerned about telehealth GLP-1s / Ozempic and Wegovy officially moved off FDA's drug shortage list / Ozempic, Eliquis, Keytruda: The 8 top-selling drugs of 2024